Abstract

Our study aimed to investigate the role of long non-coding RNAs (lncRNA) TP73-AS1 in retinoblastoma (Rb). In the present study, we found that TP73-AS1 was up-regulated, while miR-139–3p was down-regulated in Rb. TP73-AS1 and miR-139-3p were inversely correlated in Rb tissues. In cells of Rb cell lines, overexpression of miR-139-3p failed to affect TP73-AS1, while TP73-AS1 overexpression caused the down-regulated miR-139-3p. TP73-AS1 overexpression caused promoted proliferation of Rb cells but showed no significant effects on cell migration and invasion. miR-139-3p overexpression played an opposite role and attenuated the effects of TP73-AS1 overexpression. Therefore, lncRNA TP73-AS1 may down-regulate miR-139-3p to promote Rb cell proliferation.

Highlights

  • Retinoblastoma (Rb) is a common and deadly intraocular tumor that mainly affects children [1]

  • The present study investigated the involvement of TP73-AS1 in Rb and explored its functions in this disease

  • We showed that TP73-AS1 was up-regulated in Rb and promoted Rb cell proliferation by down-regulating miR-139-3p, which has been characterized as a tumor suppressive miRNA in Rb [13]

Read more

Summary

Introduction

Retinoblastoma (Rb) is a common and deadly intraocular tumor that mainly affects children [1]. One out of 18000 to 30000 live births will develop Rb worldwide [2]. Without proper treatment, development of Rb is rapid and brain metastasis is common, leading to high mortality rate [3]. Chemotherapy is usually successful in the treatment of group A–C patients, while ocular survival rate of group D after systemic chemotherapy is only 10–47% [4]. This rate in group E patients is close to 0 [5,6].

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.